Ropivacaine Hydrochloride Injection
Brand names: Naropin, Ropivacaine Hydrochloride
Category: Anesthesia
Unavailable 12Limited 3Available 34
FDA status: Current · Last FDA update: Sep 17, 2026 · First posted: Mar 23, 2018 (in shortage 8 years 6 months) · 5 manufacturers, 49 listed presentations
As of Sep 17, 2026, the FDA lists Ropivacaine Hydrochloride Injection as currently in shortage. Of 49 manufacturer presentations, 12 Unavailable, 3 Limited, 34 Available.
Ask your pharmacist: which of the 5 manufacturers below can they order right now, and whether a different strength or form of Ropivacaine Hydrochloride Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) NDC 55150-195-20 |
Eugia US LLC | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) NDC 63323-285-61 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) NDC 63323-285-20 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) NDC 63323-285-10 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) NDC 63323-285-63 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) NDC 25021-671-67 |
InfoRLife SA | Unavailable | Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) NDC 43066-015-10 |
Caplin Steriles, Ltd. | Limited | Check wholesalers for inventory; Marketed by Baxter |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) NDC 25021-671-66 |
InfoRLife SA | Limited | Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) NDC 55150-196-99 |
Eugia US LLC | Available | Check wholesalers for inventory |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) NDC 63323-285-64 |
Fresenius Kabi USA, LLC | Available | - |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) NDC 63323-285-13 |
Fresenius Kabi USA, LLC | Available | Check wholesaler for inventory |
| Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) NDC 65219-632-10 |
Fresenius Kabi USA, LLC | Available | - |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) NDC 63323-285-23 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) NDC 65219-632-20 |
Fresenius Kabi USA, LLC | Available | - |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) NDC 63323-285-65 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) NDC 25021-671-87 |
InfoRLife SA | Available | Marketed by Sagent Pharmaceuticals |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) NDC 25021-671-82 |
InfoRLife SA | Available | Marketed by Sagent Pharmaceuticals |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) NDC 70069-061-25 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) NDC 70069-062-25 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) NDC 70069-062-10 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) NDC 70069-061-10 |
Somerset Therapeutics, LLC | Available | - |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) NDC 63323-286-20 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) NDC 63323-286-31 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) NDC 43066-023-10 |
Caplin Steriles, Ltd. | Limited | Limited supply; Check wholesalers for inventory; Marketed by Baxter |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) NDC 43066-019-10 |
Caplin Steriles, Ltd. | Available | Check wholesalers for inventory; Marketed by Baxter |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) NDC 55150-198-30 |
Eugia US LLC | Available | Check wholesalers for inventory |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) NDC 55150-197-20 |
Eugia US LLC | Available | Check wholesalers for inventory |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) NDC 63323-286-23 |
Fresenius Kabi USA, LLC | Available | - |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) NDC 63323-286-63 |
Fresenius Kabi USA, LLC | Available | - |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) NDC 63323-286-00 |
Fresenius Kabi USA, LLC | Available | - |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) NDC 63323-286-35 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) NDC 25021-652-87 |
InfoRLife SA | Available | Marketed by Sagent Pharmaceuticals |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) NDC 25021-652-82 |
InfoRLife SA | Available | Marketed by Sagent Pharmaceuticals |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) NDC 70069-063-25 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) NDC 70069-064-01 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) NDC 70069-064-25 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) NDC 70069-064-10 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) NDC 55150-199-20 |
Eugia US LLC | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory |
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) NDC 63323-287-20 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) NDC 63323-287-21 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) NDC 63323-288-10 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) NDC 63323-288-20 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) NDC 43066-027-10 |
Caplin Steriles, Ltd. | Available | Check wholesalers for inventory; Marketed by Baxter |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) NDC 55150-200-10 |
Eugia US LLC | Available | Check wholesalers for inventory |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) NDC 55150-201-20 |
Eugia US LLC | Available | Check wholesalers for inventory |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) NDC 63323-288-11 |
Fresenius Kabi USA, LLC | Available | - |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) NDC 63323-288-21 |
Fresenius Kabi USA, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) NDC 70069-067-25 |
Somerset Therapeutics, LLC | Available | - |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) NDC 70069-067-10 |
Somerset Therapeutics, LLC | Available | - |
Related medications in shortage
Other Anesthesia medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Ropivacaine Hydrochloride Injection (FDA data as of Sep 17, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Ropivacaine Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Ropivacaine Hydrochloride Injection.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/ropivacaine-hydrochloride-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).